Ceribell, a medical tech company specializing in neurological care, has appointed Thomas West and Sharon O’Keefe to its Board of Directors. West brings extensive experience in scaling medical technologies commercially, while O’Keefe offers leadership from major health systems. These appointments aim to support Ceribell’s growth as it expands the use of its point-of-care brain monitoring platform, now in over 680 U.S. hospitals. The company focuses on rapid diagnosis and continuous monitoring of neurological conditions with FDA-cleared AI-powered EEG technology.
Amazon CEO Andy Jassy has sold $25 billion in bonds to finance the company's expansion of AI data centers. This move is part of Amazon's broader commitment to invest $200 billion in capital expenditures throughout 2026. The bond sale highlights Amazo...
Capital Bank has appointed James “Jay” Como III as its new Chief Operating Officer. Mr. Como will oversee enterprise operations with a focus on modernizing processes and expanding the use of data, automation, and AI to improve efficiency. He brings o...
VisionWave Holdings has filed a U.S. patent application for DeepWave RF™, a new AI-powered platform designed to sense and visualize geological formations ahead of a drill bit. This technology integrates software-defined radio, edge computing, and phy...
Siemens Energy AG, a global leader in energy technology, has upgraded its U.S. trading status to the OTCQX Best Market from the Pink Limited Market. This move allows U.S. investors better access to the company, which is expanding its U.S. operations ...
Factorial Energy and SK On have signed a Memorandum of Understanding to jointly evaluate the feasibility of manufacturing Factorial's solid-state battery technology using SK On's global lithium-ion battery production infrastructure. This partnership ...
